Literature DB >> 22270479

Impact of cigarette smoking on symptoms and quality of life of adults with asthma managed in public primary care clinics in Singapore: a questionnaire study.

Ngiap Chuan Tan1, Soh Heng Agnes Ngoh, Stephanie Swee Hong Teo, Teck Sin Swah, Zhaojin Chen, Bee Choo Tai.   

Abstract

BACKGROUND: Cigarette smoking aggravates asthma exacerbations, yet some patients with asthma continue to smoke. AIMS: To compare the quality of life of adult smokers and non-smokers with asthma.
METHODS: Asthma Quality of Life (AQLQ) questionnaires were administered to adult patients with asthma managed in primary care in Singapore. The survey also included data of their asthma status including symptom profiles. Independent two-sample t-test, ANCOVA model, χ2 test and ordinal logistic regression were used to compare the mean domain scores and the effect of smoking on nocturnal symptoms and awakening, respectively.
RESULTS: 357 adult asthma patients (183 non-smokers and 174 smokers) were recruited. Smokers were mainly male (p<0.001), single (p=0.008), and younger (mean age 30 years) (p=0.007). They were more affected by nocturnal cough and wheezing (p=0.016). After adjustment for age, gender, and asthma medications, the mean scores of the AQLQ 'symptoms' and 'emotional function' domains of smokers were 0.41 (95% CI 0.10 to 0.72) and 0.50 (95% CI 0.16 to 0.84) points lower than for non-smokers, with no statistical differences in the 'activity limitations' and 'exposure to environmental stimuli' domains.
CONCLUSIONS: Adult patients with asthma who smoke are more affected by nocturnal symptoms, with lower 'emotional function' scores in the AQLQ.

Entities:  

Mesh:

Year:  2012        PMID: 22270479      PMCID: PMC6547905          DOI: 10.4104/pcrj.2012.00003

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  8 in total

1.  The Prevalence of Asthma in an Adult Population in Khorramabad, Iran.

Authors:  A Amiri; S Asadi; V Almasi; A Ghobadi
Journal:  West Indian Med J       Date:  2014-05-08       Impact factor: 0.171

2.  Ten-year longitudinal study of factors influencing nocturnal asthma symptoms among Asian patients in primary care.

Authors:  Ngiap Chuan Tan; Nivedita V Nadkarni; Weng Kit Lye; Usha Sankari; van Hai Nguyen
Journal:  NPJ Prim Care Respir Med       Date:  2015-10-29       Impact factor: 2.871

3.  Association between Disease-Specific Quality of Life and Complementary Medicine Use in Patients with Rhinitis in Taiwan: A Cross-Sectional Survey Study.

Authors:  Malcolm Koo; Kai-Li Liang; Rong-San Jiang; Hsin Tsao; Yueh-Chiao Yeh
Journal:  Evid Based Complement Alternat Med       Date:  2014-10-28       Impact factor: 2.629

4.  Impact of asthma on women and men: Comparison with the general population using the EQ-5D-5L questionnaire.

Authors:  Gimena Hernandez; Alexandra L Dima; Àngels Pont; Olatz Garin; Marc Martí-Pastor; Jordi Alonso; Eric Van Ganse; Laurent Laforest; Marijn de Bruin; Karina Mayoral; Montse Ferrer
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

5.  Association of quality of life and disease control with cigarette smoking in patients with severe asthma.

Authors:  V C H Dos Santos; M A F Moreira; A V da Rosa; S M Sobragi; C A J da Silva; P T R Dalcin
Journal:  Braz J Med Biol Res       Date:  2022-01-05       Impact factor: 2.590

6.  The Association Between Smoking and Health-Related Quality of Life Among Chinese Individuals Aged 40 Years and Older: A Cross-Sectional Study.

Authors:  Xi Cheng; Chenggang Jin
Journal:  Front Public Health       Date:  2022-02-24

7.  Cigarette Smoking and Skin Prick Test in Patients With Allergic Rhinitis.

Authors:  Hossein Ali Khazaei; Bahman Khazaei; Gholam Ali Dashtizadeh; Mahdi Mohammadi
Journal:  Int J High Risk Behav Addict       Date:  2015-09-01

8.  Efficacy of guided self-change for smoking cessation in chronic obstructive pulmonary disease patients: A randomized controlled clinical trial.

Authors:  Mehran Zarghami; Fatemeh Taghizadeh; Ali Sharifpour; Abbas Alipour
Journal:  Tob Induc Dis       Date:  2019-12-11       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.